THE
3002.12.90

Tariff line in 3002.12 — Antisera and other blood fractions and modified immunological products, whether or not obtained by m

Antisera and other blood fractions and modified immunological products, whether or not obtained by m

$132MIndia’s exports in FY 2025-26
127countries bought from India
+21%against FY 2024-25 ($109M)
591tonnes shipped in FY 2025-26

India’s exports, year by year

US$, Indian financial years (April–March). Source: DGCI&S, Ministry of Commerce (Tradestat).

Biggest buyers, FY 2025-26

  1. Sri Lanka
  2. United Arab Emirates
  3. Chile
  4. Philippines
  5. Peru
  6. Colombia
  7. El Salvador
  8. Dominican Republic
  9. Kenya
  10. Bangladesh

Ranked by value. Country-by-country figures are not shown.

GST on this code

0% or 5%

  • 5% — Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures whether or not modifiedNotification 9/2025-CT(R), Schedule I, entry 231
  • 5% — Animal or Human Blood VaccinesNotification 9/2025-CT(R), Schedule I, entry 232
  • 0% — Human Blood and its componentsNotification 10/2025-CT(R), entry 114

GST on supply within India, as of 1 May 2026. Exports are zero-rated supplies.

Other codes in 3002.12